Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6

Page created by Nathan Hicks
 
CONTINUE READING
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
Caterina Buonocore, Health NCP,
Coordinator of the «HNN3.0 NCP
project» and Cluster 1 team, CL6
buonocore@apre.it
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
Summary

 Health cluster : main structure , African perfomance
 EDCTP 3 : a longstanding collaboration EU- Sub saharan Africa
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
HEALTH RESEARCH
                                                   ERC
WHERE CAN YOU                                    (Pillar I)
FIND IT?                  Pillar III                                      MSCA
                          «Innovative
                            Europe»                                      (Pillar I)
COMPLEMENTARITIES
WITH OTHER PILLARS                           Cluster 1
AND CLUSTERS         Cluster 6 –
                                              Health
                                                                                 Research
                        Food,                    (Pillar II)                  Infrastructure
                     bioeconom
                                                                               (Pillar I)
                         y…

                                   Cluster 4 –                 Cluster 3 –
                                     Digital,                     Civil
                                    Industry                   security for
                                   and Space                     society
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
Complementarietà cross-                                           Cluster 2 –
                                                                   Inclusive
clusters con tutte le aree del                                      society

2° Pilastro
                                                    Cluster 6 –                 Cluster 3 –
 Alcuni esempi                                         Food,                       Civil
CL 2. Ageing society ..inclusive society..          bioeconom     Cluster 1     security for
CL 3. Cybersecurity of health data, protection of       y…                        society
critical infrastructures, reaction to pandemics..
Improving response to domestic violence
CL 4. Robotics, Smart materials, training of
healthcare professionals, photonics..
CL6. Healthy Food and nutrition, …                                Cluster 4 –
                                                                    Digital
                                                                   Industry
                                                                  and Space
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
WORK PROGRAMME “HEALTH” 2021-2024
6 Destinations
1. Staying Healthy in a rapid changing society
2. Living and working in a health-promoting environment
3. Tackling diseases and reducing disease burden
4. Ensuring access to innovative, sustainable and high-quality health
   care
5. Unlocking the full potential of new tools, technologies and digital
   solutions for a healthy society
6. Maintaining an innovative, sustainable and
globally competitive health industry

 12/09/2022                                                              5
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
Horizon Europe – Cluster 1 “Health“
                                                                                      Calls for
Strategic Plan 2021-24 (link)* → 6 Expected Impacts                                  proposals:
                                                                                        50%
         Work Programme 2021-22 (link)*
      6 “Destinations”                        →         Topics (Calls)

 1. Staying healthy in a rapidly changing society               Focus on outcomes contributing to the
 2. Living and working in a health-promoting                    impacts specified per Destination
    environment
 3. Tackling diseases & reducing disease burden                 Project proposals should
                                                                ➢ make a clear case (value proposition)
 4. Ensuring access to innovative, sustainable
                                                                ➢ supported by a convincing trajectory
    & high-quality healthcare
                                                                  (pathway to impact) for the project
 5. Unlocking the full potential of new tools,                    proposal to deliver the output, promote
    technologies                                                  the outcome described in the topic, and
    and digital solutions for a healthy society                   contribute to the impact expected under
 6. Maintaining an innovative, sustainable & globally             that destination.
    competitive health industry
  6
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
Impact statements/destinations of Cluster 1 ‘Health
1.Staying healthy in a rapidly changing society: Citizens of all ages stay healthy and independent in a rapidly changing society
  thanks to healthier lifestyles and behaviours, healthier diets, healthier environments, improved evidence-based health policies,
  and more effective solutions for health promotion and disease prevention.
2.Living and working in a health-promoting environment: Living and working environments are health-promoting and
  sustainable thanks to better understanding of environmental, occupational, social and economic determinants of health.
3. Tackling diseases and reducing disease burden: Health care providers are able to better tackle and manage diseases (infectious
  diseases, including poverty-related and neglected diseases, non-communicable and rare diseases) and reduce the disease
  burden on patients effectively thanks to better understanding and treatment of diseases, more effective and innovative health
  technologies, better ability and preparedness to manage epidemic outbreaks and improved patient safety.
4. Ensuring access to innovative, sustainable and high-quality health care: Health care systems provide equal access to innovative,
  sustainable and high-quality health care thanks to the development and uptake of safe, cost-effective and people-centred
  solutions, with a focus on population health, health systems resilience, as well as improved evidence-based health policies.
5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society: Health technologies, new tools
  and digital solutions are applied effectively thanks to their inclusive, secure and ethical development, delivery, integration and
  deployment in health policies and health and care systems.
6. Maintaining an innovative, sustainable and globally competitive health-related industry: EU health industry is innovative,
  sustainable and globally competitive thanks to improved up-take of breakthrough technologies and innovations, which makes
  the EU with its Member States more resilient and less dependent from imports with regard to the access to and supply of
  critical health technologies.
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
CLUSTER HEALTH | DESTINATION 1

      Staying healthy in a rapidly
     changing society
                                                                             TOPICS 2022:
▪ Affronta le principali sfide sociali come l'obesità,      ✓ Boosting mental health in Europe in times of
  l'invecchiamento e il cambiamento demografico,               change – RIA
  la salute mentale, l’empowerment nell’ambito              ✓ Trustworthy artificial intelligence (AI) tools to
  della digital health literacy, la prevenzione                predict the risk of chronic non-communicable
  personalizzata e l'Intelligenza Artificiale applicata        diseases and/or their progression – RIA
  alle malattie croniche.                                   ✓ Prevention of obesity throughout the life course –
     ▪ Progetti di ricerca e innovazione che                   RIA
        forniscano nuove evidenze, metodologie e          Deadline: 1 February /6 September 2022 – TWO-STAGE
        strumenti per comprendere la transizione
        dalla salute alla malattia.                         ✓ Personalised blueprint of chronic inflammation in
                                                              health-to-disease transition – RIA
                                                                 Deadline: 21 April 2022 – SINGLE STAGE
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
CLUSTER HEALTH | DESTINATION 2

        Living and working in
       a health-promoting
       environment*
▪ Comprendere gli impatti dell'inquinamento atmosferico                         TOPICS 2023:
  indoor/outdoor, delle sostanze chimiche, dei campi             HORIZON-HLTH-2023-ENVHLTH-02-01:
  elettromagnetici, dell'urbanizzazione, del cambiamento         Planetary health: understanding the links between
  climatico e di altri cambiamenti ambientali, delle             environmental degradation and health impacts
  disuguaglianze socioeconomiche e del cambiamento degli
  ambienti di lavoro.
▪ Rafforzare la capacità di adattamento e la resilienza delle
  popolazioni e dei sistemi sanitari rispetto ai rischi per la
  salute legati ai cambiamenti climatici e ambientali.

* Forte connessione con European Green Deal e Cluster 6, Mission Climate
Caterina Buonocore, Health NCP, Coordinator of the "HNN3.0 NCP project" and Cluster 1 team, CL6
CLUSTER HEALTH | DESTINATION 3

      Tackling diseases
                                                                         TOPICS 2022:
     and reducing                                                        ✓ Pre-clinical development of the next generation of
     disease burden*                                                       immunotherapies for diseases or disorders with unmet
                                                                           medical needs - RIA
     ▪ Si concentra sulle principali sfide sociali come il cancro, le    ✓ Vaccines 2.0 - developing the next generation of vaccines –
       malattie non trasmissibili, le malattie rare, la resistenza         RIA
                                                                         ✓ Development of new effective therapies for rare diseases –
       antimicrobica, la vaccinazione e la preparazione alle
                                                                           RIA
       epidemie.
     ▪ Sviluppo di nuove misure di prevenzione, terapie e               Scadenza: 1 Febbraio/6 Settembre 2022 – TWO-STAGE
       tecnologie sanitarie innovative.
                                                                         ✓ Pandemic preparedness - RIA
                                                                         ✓ Non-communicable diseases risk reduction in adolescence
                                                                           and youth (Global Alliance for Chronic Diseases - GACD) - RIA
                                                                         ✓ Support for the functioning of the Global Research
                                                                           Collaboration for Infectious Disease Preparedness (GloPID-R)
* Complementare a Europe’s Beating Cancer
                                                                           – CSA
Plan e EU4Health Programme                                               ✓ European partnership fostering a European Research Area
                                                                           (ERA) for health research – Placeholder – Programme Co-fund Action
                                                                                Scadenza: 21 Aprile 2022 – SINGLE STAGE
CLUSTER HEALTH | DESTINATION 4

        Ensuring access to innovative,
       sustainable and high-quality
       care*
 ▪ Sviluppo e adozione di soluzioni sicure, convenienti e                               TOPICS 2022:
   incentrate sulle persone, con particolare attenzione alla        ✓ Pre-commercial research and innovation procurement
   salute della popolazione, alla resilienza dei sistemi sanitari     (PCP) for building the resilience of health care systems
   e alle politiche sanitarie basate sull'evidenza scientifica.       in the context of recovery - PCP
     ▪ R&I per supportare i sistemi sanitari nella loro             ✓ Public procurement of innovative solutions (PPI) for
         trasformazione per garantire un accesso equo a               building the resilience of health care systems in the
         servizi sanitari sostenibili di alta qualità per tutti i     context of recovery – PPI
         cittadini.                                                 ✓ Better financing models for health systems – RIA
                                                                    ✓ European partnership on transforming health and care
                                                                      systems – Programme Co-fund Action
* Forte sinergia con EU4Health Programme                                     Deadline: 21 April 2022– SINGLE STAGE
CLUSTER HEALTH | DESTINATION 5

       Unlocking the full potential of
      new tools, technologies and                                              TOPICS 2022:
      digital solutions for a healthy                        ✓ Optimizing effectiveness in patients of existing
      society*                                                 prescription drugs for major diseases (except
▪ Promuovere lo sviluppo di strumenti, tecnologie e            cancer) with the use of biomarkers - RIA
  soluzioni digitali per trattamenti, farmaci,               ✓ New methods for the effective use of real-world
  dispositivi medici, tenendo in considerazione                data and/or synthetic data in regulatory decision-
  sicurezza, efficacia, adeguatezza, accessibilità e           making and/or in health technology assessment –
  valore aggiunto.                                             RIA
    ▪ I dati sanitari e gli strumenti analitici innovativi         Deadline: 21 April 2022– SINGLE STAGE
       vengono utilizzati in modo sicuro ed etico.
                                                             ✓ Computational models for new patient
                                                               stratification strategies - RIA
* [!] European Health Data Space per promuovere lo
scambio di dati sanitari e la ricerca transfrontaliera.      Deadline: 1 February/6 September 2022 – TWO-STAGE
CLUSTER HEALTH | DESTINATION 6

  Maintaining an innovative,
 sustainable and globally
 competitive health industry*
▪ Adozione di tecnologie e innovazioni rivoluzionarie    TOPICS 2022:
  in grado di integrare gli attori della catena del      ✓ Enhancing cybersecurity of connected medical devices -
  valore.                                                   RIA
                                                         ✓ Scaling up multi-party computation, data anonymisation
    ▪ L'industria sanitaria dell'UE è più competitiva,
                                                            techniques, and synthetic data generation – RIA
       sostenibile e strategicamente autonoma.           ✓ New pricing and payment models for cost-effective and
                                                            affordable health innovations – RIA
                                                         ✓ Setting up a European Smart Health Innovation Hub –
                                                            CSA
                                                         ✓ Setting up a European Electronic Health Record Exchange
                                                            Format (EEHRxF) Ecosystem - CSA
                                                              Scadenza : 21 Aprile 2022 – SINGLE STAGE
FUTURE 2023-2024 : Remaining indicative timetable
WP23-24 preparation
 Mid July 2022: ISC draft shared with PC
 Nov 2022: Formal consultation of Programme Committee configurations
 December 2022: Adoption of WP2023-2024 and publication

WP23-24 implementation
  Mid-April 2023: deadline for single stage 2023 calls
  Mid-September 2023: deadline for 1st stage of 2-stage calls of 2024
  Mid-April 2024: deadline for single stage 2024 calls and for 2nd stage of 2-
 stage calls of 2024
Cluster 1 Health | Success rate of African organizations: 11,7 %
 238 Eligible applications
 28 participations in funded projects
Health | Key Figures
Health | Top Funded Projects
Horizon Europe «Health» & Africa
  Some examples of Calls for proposals
Types of research

  EDCTP supports observation and interventional studies, with
 interventional trials making up the bulk of the EDCTP portfolio.
  We support phase I–III safety/efficacy studies, with an emphasis on
 phase II and III trials.
  We also support phase IV, pharmacovigilance and post-licensing
 effectiveness studies (pragmatic trials, utility/impact studies),
 product-focused implementation research and field trials, as well as
 trials of medical diagnostics to detect and monitor disease.
EDCTP3 Association | About membership

  http://www.edctp.org/about-us/governance/membership-edctp-
 association/
EDCTP3 | Important links

• Funding and Tenders Portal link to the Global Health EDCTP3 topics
• Global Health EDCTP3 (interim) website
• Work programme text published on the Global Health EDCTP3
  website
• Research Enquiry Service | European Commission (europa.eu)
• Open consultation for the AU-EU Innovation Agenda
EU Global Health Initiatives | Multi-lateral health research activities

  Global Research Collaboration for Infectious Disease Preparedness
 (GloPID-R)
 ▪ GloPID-R is a network of research funding
   organizations in the area of infectious disease
   preparedness research, aimed to facilitate an
   effective research response of a new or re-emerging
   infectious disease with epidemic and pandemic
   potential, in order to save lives and economies
   worldwide.
 ▪ GloPID-R has 32 members worldwide. The World
   Health Organization, the Coalition for Epidemic
   Preparedness Innovations (CEPI), the European &
   Developing Countries Clinical Trials Partnership
   (EDCTP) and ESSENCE on Health Research initiative are
   also actively engaged in the network.
      ▪ HHS – Department of Health and Human Services (US)
      ▪ Bill and Melinda Gates Foundation (US)
EU Global Health Initiatives | Multi-lateral health research activities

  Global Research Collaboration for Infectious Disease Preparedness
 (GloPID-R)
 ▪ GloPID-R is also
                                                                  CHECK “RESOURCES”: current
   actively involved in                                           list of downloadable learning
   systemic                                                             resources of funding
                                                                  opportunities, webinars and
   preparedness,                                                     publications, all of which
   connecting clinical                                               have been developed by
                                                                         GloPID-R members
   trial networks,
   building a framework                                       https://www.glopid-r.org/resources/
   for data sharing and
   improving the rapid
   delivery of research
   funding.
EU Global Health Initiatives | Multi-lateral health research activities

  Global Alliance for Chronic Diseases
 (GACD)

  https://www.gacd.org/funding/current-call-for-applications
CHIEDI SUPPORTO AI
TEAM TEMATICI IN APRE

i   www.horizon-europe.it
Email:
buonocore@apre.it
cluster1@pre.it
 Tel. +39 06 48 93 9993
   www.apre.it
You can also read